Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 145

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis

Olivero, Christiane E., Martínez-Terroba, Elena, Zimmer, Joshua, Liao, Clara, Tesfaye, Ephrath, Hooshdaran, Nima, Schofield, Jeremy A., Bendor, Jordan, Fang, Dorthy, Simon, Matthew D., Zamudio, Jesse R., Dimitrova, Nadya · 2020 · Molecular Cell

Abstract

The tumor suppressor p53 transcriptionally activates target genes to suppress cellular proliferation during stress. p53 has also been implicated in the repression of the proto-oncogene Myc, but the mechanism has remained unclear. Here, we identify Pvt1b, a p53-dependent isoform of the long noncoding RNA (lncRNA) Pvt1, expressed 50 Kb downstream of Myc, which becomes induced by DNA damage or oncogenic signaling and accumulates near its site of transcription. We show that production of the Pvt1b RNA is necessary and sufficient to suppress Myc transcription in cis without altering the chromatin organization of the locus. Inhibition of Pvt1b increases Myc levels and transcriptional activity and promotes cellular proliferation. Furthermore, Pvt1b loss accelerates tumor growth, but not tumor progression, in an autochthonous mouse model of lung cancer. These findings demonstrate that Pvt1b acts at the intersection of the p53 and Myc transcriptional networks to reinforce the anti-proliferative activities of p53.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2019.12.014

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 53

  1. Anders, 2015, HTSeq—a Python framework to work with high-throughput sequencing data, Bioinformatics, 31, 166, 10.1093/bioinformatics/btu638 · DOI · Paper page
  2. Barsotti, 2012, p53-dependent induction of PVT1 and miR-1204, J. Biol. Chem., 287, 2509, 10.1074/jbc.M111.322875 · DOI · Paper page
  3. Bassett, 2014, Considerations when investigating lncRNA function in vivo, eLife, 3, e03058, 10.7554/eLife.03058 · DOI · Paper page
  4. Chaumeil, 2008, Combined immunofluorescence, RNA fluorescent in situ hybridization, and DNA fluorescent in situ hybridization to study chromatin changes, transcriptional activity, nuclear organization, and X-chromosome inactivation, Methods Mol. Biol., 463, 297, 10.1007/978-1-59745-406-3_18 · DOI
  5. Cho, 2018, Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element, Cell, 173, 1398, 10.1016/j.cell.2018.03.068 · DOI · Paper page
  6. Clarke, 1994, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation, Oncogene, 9, 1767
  7. Conrad, 2017, Cellular fractionation and isolation of chromatin-associated RNA, Methods Mol. Biol., 1468, 1, 10.1007/978-1-4939-4035-6_1 · DOI
  8. Cory, 1985, Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene, EMBO J., 4, 675, 10.1002/j.1460-2075.1985.tb03682.x · DOI · Paper page
  9. Cui, 2016, Long non-coding RNA PVT1 and cancer, Biochem. Biophys. Res. Commun., 471, 10, 10.1016/j.bbrc.2015.12.101 · DOI
  10. Dahlman, 2015, Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease, Nat. Biotechnol., 33, 1159, 10.1038/nbt.3390 · DOI · Paper page
  11. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  12. DuPage, 2009, Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase, Nat. Protoc., 4, 1064, 10.1038/nprot.2009.95 · DOI · Paper page
  13. Elling, 2018, Genetic models reveal cis and trans immune-regulatory activities for lincRNA-Cox2, Cell Rep., 25, 1511, 10.1016/j.celrep.2018.10.027 · DOI
  14. Engeland, 2018, Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM, Cell Death Differ., 25, 114, 10.1038/cdd.2017.172 · DOI · Paper page
  15. Feldser, 2010, Stage-specific sensitivity to p53 restoration during lung cancer progression, Nature, 468, 572, 10.1038/nature09535 · DOI · Paper page
  16. Graham, 1986, Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt’s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus, EMBO J., 5, 2845, 10.1002/j.1460-2075.1986.tb04578.x · DOI
  17. Graham, 1985, Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations, Nature, 314, 740, 10.1038/314740a0 · doi:10.1038/314740a0
  18. Groff, 2016, In vivo characterization of linc-p21 reveals functional cis-regulatory DNA elements, Cell Rep., 16, 2178, 10.1016/j.celrep.2016.07.050 · DOI
  19. Guan, 2007, Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer, Clin. Cancer Res., 13, 5745, 10.1158/1078-0432.CCR-06-2882 · DOI · Paper page
  20. Guo, 2018, Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2, Cancer Cell Int., 18, 98, 10.1186/s12935-018-0582-3 · DOI
  21. Ho, 2005, p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest, Mol. Cell. Biol., 25, 7423, 10.1128/MCB.25.17.7423-7431.2005 · DOI · Paper page
  22. Iwakawa, 2013, Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer, Genes Chromosomes Cancer, 52, 802, 10.1002/gcc.22076 · DOI
  23. Jackson, 2001, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras, Genes Dev., 15, 3243, 10.1101/gad.943001 · DOI · Paper page
  24. Jackson, 2005, The differential effects of mutant p53 alleles on advanced murine lung cancer, Cancer Res., 65, 10280, 10.1158/0008-5472.CAN-05-2193 · DOI · Paper page
  25. Kim, 2014, Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis, Oncogene, 33, 5434, 10.1038/onc.2013.490 · DOI
  26. Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 · DOI · Paper page
  27. Kong, 2015, Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16, Mol. Cancer, 14, 82, 10.1186/s12943-015-0355-8 · DOI · Paper page
  28. Kopp, 2018, Functional classification and experimental dissection of long noncoding RNAs, Cell, 172, 393, 10.1016/j.cell.2018.01.011 · DOI · Paper page
  29. Kotzin, 2016, The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan, Nature, 537, 239, 10.1038/nature19346 · DOI · Paper page
  30. Lee, 2012, Epigenetic regulation by long noncoding RNAs, Science, 338, 1435, 10.1126/science.1231776 · DOI · Paper page
  31. Levy, 1993, Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression, Mol. Cell. Biol., 13, 7942
  32. Li, 2009, The Sequence Alignment/Map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
  33. Lin, 2012, Transcriptional amplification in tumor cells with elevated c-Myc, Cell, 151, 56, 10.1016/j.cell.2012.08.026 · DOI · Paper page
  34. Nagoshi, 2012, Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality, Cancer Res., 72, 4954, 10.1158/0008-5472.CAN-12-0213 · DOI
  35. Northcott, 2012, Subgroup-specific structural variation across 1,000 medulloblastoma genomes, Nature, 488, 49, 10.1038/nature11327 · DOI · Paper page
  36. Pertea, 2015, StringTie enables improved reconstruction of a transcriptome from RNA-seq reads, Nat. Biotechnol., 33, 290, 10.1038/nbt.3122 · DOI · Paper page
  37. Platt, 2014, CRISPR-Cas9 knockin mice for genome editing and cancer modeling, Cell, 159, 440, 10.1016/j.cell.2014.09.014 · DOI · Paper page
  38. Porter, 2017, Global inhibition with specific activation: how p53 and MYC redistribute the transcriptome in the DNA double-strand break response, Mol. Cell, 67, 1013, 10.1016/j.molcel.2017.07.028 · DOI
  39. Riquelme, 2014, Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma, J. Thorac. Oncol., 9, 998, 10.1097/JTO.0000000000000202 · DOI
  40. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  41. Sachdeva, 2009, p53 represses c-Myc through induction of the tumor suppressor miR-145, Proc. Natl. Acad. Sci. U S A, 106, 3207, 10.1073/pnas.0808042106 · DOI · Paper page
  42. Schofield, 2018, TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding, Nat. Methods, 15, 221, 10.1038/nmeth.4582 · DOI · Paper page
  43. Stewart, 2003, Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, 9, 493, 10.1261/rna.2192803 · DOI · Paper page
  44. Trapnell, 2009, TopHat: discovering splice junctions with RNA-Seq, Bioinformatics, 25, 1105, 10.1093/bioinformatics/btp120 · DOI · Paper page
  45. Tseng, 2015, The PVT1-MYC duet in cancer, Mol. Cell. Oncol., 2, e974467, 10.4161/23723556.2014.974467 · DOI
  46. Tseng, 2014, PVT1 dependence in cancer with MYC copy-number increase, Nature, 512, 82, 10.1038/nature13311 · DOI · Paper page
  47. Xu, 2012, FastUniq: a fast de novo duplicates removal tool for paired short reads, PLoS ONE, 7, e52249, 10.1371/journal.pone.0052249 · DOI · Paper page
  48. Xu, 2017, A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion, Clin. Cancer Res., 23, 2071, 10.1158/1078-0432.CCR-16-0742 · DOI · Paper page
  49. Zeng, 2017, LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis, Oncotarget, 8, 75455, 10.18632/oncotarget.20634 · DOI
  50. Zhang, 2019, Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a, Exp. Ther. Med., 17, 1337
  51. Zhao, 2018, LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448, J. Cell. Physiol., 233, 4044, 10.1002/jcp.26072 · DOI
  52. Zheng, 2016, High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer, Oncol. Lett., 12, 2357, 10.3892/ol.2016.5026 · DOI
  53. Zhu, 2017, Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis, Oncotarget, 8, 113174, 10.18632/oncotarget.22830 · doi:10.18632/oncotarget.22830

Cited by

Metadata

Authors
Olivero, C. E., Martínez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., Schofield, J. A., Bendor, J., Fang, D., Simon, M. D., Zamudio, J. R., & Dimitrova, N.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2020-02
Volume
77
Issue
4
Pages
761-774.e8
ISSN
1097-2765
Cited by
145
References
12
Language
en
Licence
Funders
  • American Cancer Society (IRG-ACS 58-012-58)
  • National Institutes of Health
  • National Cancer Institute (R37CA230580)
  • Yale University (T32GM007223)
  • V Foundation for Cancer Research
  • Lung Cancer Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.